EBIT: Income before interest and taxes.
Atossa Genetics Inc. (ATOS) had EBIT of $-37.14M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-34.77M |
|
-- |
|
-- |
|
$37.14M |
|
$-37.14M |
|
$2.37M |
|
$-34.77M |
|
$-34.77M |
|
$-34.77M |
|
$-34.77M |
|
$-34.77M |
|
$-34.77M |
|
|
EBIT |
$-37.14M |
$-37.12M |
|
8.61M |
|
8.61M |
|
$-4.04 |
|
$-4.04 |
|
| Balance Sheet Financials | |
$45.62M |
|
-- |
|
$1.99M |
|
$47.61M |
|
$8.26M |
|
-- |
|
-- |
|
$8.26M |
|
$39.35M |
|
$39.35M |
|
$39.35M |
|
8.61M |
|
| Cash Flow Statement Financials | |
$-29.76M |
|
$-0.02M |
|
-- |
|
$71.19M |
|
$41.41M |
|
$-29.79M |
|
$2.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-29.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-88.35% |
|
-88.35% |
|
-73.03% |
|
-88.35% |
|
$4.57 |
|
$-3.46 |
|
$-3.46 |
|